aap: Growth in Q3 and 9M/2018 with sales and EBITDA in line with guidance; Milestone in silver coating technology on way to human study
(WorldNews Germany)

aap Implantate AG ("aap") achieved sales and EBITDA in line with the guidance in the third quarter of 2018. Sales in the third quarter of 2018 grew by 5% on the corresponding period in the previous year to EUR 2.7 million (Q3/2017: EUR 2.6 million) and were therefore within the forecast of EUR 2.0 million to EUR 3.8 million. EBITDA improved by 6% in the third quarter of 2018 year-on-year to EUR -1.5 million (Q3/2017: EUR -1.6 million) and was thus also in line with the guidance of EUR -1.8 million to EUR -0.9 million. With respect to the nine-month period, sales increased by 2% to EUR 8.2 million (9M/2017: EUR 8.0 million). EBITDA improved by 6% in the first nine months of 2018...